advertisement
Advances in Therapy 15
Showing records 1 to 15 | Display all abstracts in Advances in Therapy81112 Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
Hengerer FH
Advances in Therapy 2019; 36: 1606-1617
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Parisi V
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Hernstadt DJ
Advances in Therapy 2019; 36: 976-986
81112 Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
Auffarth GU
Advances in Therapy 2019; 36: 1606-1617
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Cheng J
Advances in Therapy 2019; 36: 976-986
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Oddone F
Advances in Therapy 2019; 36: 987-996
81112 Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
Riffel C
Advances in Therapy 2019; 36: 1606-1617
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Roberti G
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Htoon HM; Sangtam T; Sangtam T
Advances in Therapy 2019; 36: 976-986
81112 Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
Conrad-Hengerer I
Advances in Therapy 2019; 36: 1606-1617
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Tanga L; Carnevale C
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Thomas A
Advances in Therapy 2019; 36: 976-986
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Carnevale C
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Sng CCA
Advances in Therapy 2019; 36: 976-986
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Ziccardi L; Manni G
Advances in Therapy 2019; 36: 987-996
